Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York
Date:6/17/2008

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the corporate overview on Monday, June 23, 2008 at 1:05pm Eastern Time (10:05am Pacific Time) during the Leerink Swann Pain Roundtable Conference at the Sofitel Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at http://www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 90 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance(TM) (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Cadence(TM), Acetavance(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

Contacts: William R. LaRue Anna Gralinska

SVP & Chief Financial Officer Director, Inv
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008
2. Cadence Pharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference on March 20, 2008 in Boston
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
4. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
5. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
6. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
7. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2007 Financial Results
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIOCOM Investor Conference 2007
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BIO Investor Forum
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
11. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 Research ... the addition of the "Global Biometric ... report to their offering.      ... data protection and old security practises such ... driven the growth of biometric technologies in ...
(Date:6/19/2013)... 19, 2013 MO BIO Laboratories, Inc., ... challenging microbial nucleic acid purification, announces the launch ... extraction of pure protein from all soil types. ... the 20 th anniversary of the company ... (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ) ...
(Date:6/19/2013)... Bayer CropScience will honor Illinois beekeeper Steve ... Leadership Award. The award will be announced at Bayer’s ... D.C., an event where supporters of pollinator health celebrate ... , The Bayer Bee Care Community Leadership Award ... honey bee colony to benefit their community. Applicants are ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
Breaking Biology Technology:Global Biometric Systems Market Forecast Report - Opportunities to 2018 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 3MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3
... SOUTH SAN FRANCISCO, Calif., Dec. 21 Anesiva,Inc. ... of its public offering,of 11,111,111 shares of its ... their option to purchase an additional 1,234,568 shares.,The ... from the sale of the aggregate 12,345,679 shares ...
... a,subsidiary of MGT Capital Investments, Inc. (Amex: ... of Computer-Aided Detection (CAD) and image,analysis software which ... initiative by Barbara Cubin, Republican Representative for Wyoming, ... Tomography,Colonography (CTC). CTC is the innovative screening test ...
... Pacific Northwest, SEATTLE, Dec. 21 Steadfast ... Washington state congressional delegation has,resulted in $2.1 million ... state-of-the-art proton-beam therapy center by the Seattle Cancer ... 2008 Omnibus Appropriations,bill signed by President Bush on ...
Cached Biology Technology:Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer 2Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer 3Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer 4Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer 5Murray Leads Delegation in Securing $2.1 Million for Proton Therapy Center 2Murray Leads Delegation in Securing $2.1 Million for Proton Therapy Center 3
(Date:6/19/2013)... Amsterdam, June 19, 2013 Elsevier, a world-leading provider ... is pleased to announce the launch of a new ... the launch of GeoResJ , Elsevier,s earth and ... only journal. The journal aims to provide a forum ... earth science field. The journal will be co-edited by ...
(Date:6/18/2013)... hacker lab. At Brandeis University, sophisticated computational models ... scientists understand the complex interplay between genomic data, ... outer "shell" critical for replication. ... are finding will help researchers alter virus assembly, ... Jason Perlmutter, first author of the scientific paper ...
(Date:6/18/2013)... Molecular Pathology is proud to announce it will join ... on July 1, 2013. The FASEB Board approved AMP,s ... The 26 constituent societies of FASEB represent more than ... advancement of research and education in biological and biomedical ... now than ever," said Jennifer L. Hunt, MD, MEd, ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2
... UC engineering researchers create tiny pools without ... typically depend upon electrokinetic or traditional pressure methods ... fixed microchip. As just published as ... Chip, " in "Virtual electrowetting channels: electronic liquid ...
... A high dietary intake of phosphate promotes tumor ... at Emory University School of Medicine have found. The ... , suggest that a high intake of phosphates may ... skin cancer, while restricting phosphate intake may help prevent ...
... Amlie Perez is preparing to tally the number of ... a row. The objective? To measure the impact of the ... the amphibian populations of southern Quebec. A graduate student ... visit more than 50 swamps and lakes. Last year she ...
Cached Biology News:A lab-on-a-chip with moveable channels 2High dietary phosphate intake may promote skin cancer formation 2High dietary phosphate intake may promote skin cancer formation 3Counting frogs: Why monitoring our amphibian populations is important 2
IgG2b, k APC clone A95-1, Isotype Rat IgG2b, kappa, 0.1 mg ....
Mouse BLC/BCA 1 - 10kDa...
Bag-1 (K-20)...
... PGE2-d4 contains 4 deuterium atoms at ... It is intended for use as an ... E2 (PGE2) by GC- or LC-mass spectrometry. ... products of arachidonic acid and one of ...
Biology Products: